BCL2L13 Antikörper (Middle Region)
-
- Target Alle BCL2L13 Antikörper anzeigen
- BCL2L13 (BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13))
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BCL2L13 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Purified
- Immunogen
- BCL2 L13 antibody was raised in rabbit using the middle region of BCL2 13 as the immunogen
- Top Product
- Discover our top product BCL2L13 Primärantikörper
-
-
- Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
BCL2L13 Blocking Peptide, catalog no. 33R-9493, is also available for use as a blocking control in assays to test for specificity of this BCL2L13 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- BCL2L13 (BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13))
- Andere Bezeichnung
- BCL2L13 (BCL2L13 Produkte)
- Synonyme
- si:ch211-238n5.7 antikoerper, Mil1 antikoerper, BCL-RAMBO antikoerper, Bcl2-L-13 antikoerper, MIL1 antikoerper, E430016C20Rik antikoerper, Mil-1 antikoerper, BCL2 like 13 antikoerper, BCL2-like 13 (apoptosis facilitator) antikoerper, BCL2L13 antikoerper, bcl2l13 antikoerper, Bcl2l13 antikoerper
- Hintergrund
- BCL2L13 May promote the activation of caspase-3 and apoptosis. Synonyms: Polyclonal BCL2L13 antibody, Anti-BCL2L13 antibody, BCL2-like 13, apoptosis facilitator antibody, BCL-RAMBO antibody, MIL1 antibody.
- Pathways
- Positive Regulation of Endopeptidase Activity
-